Gut colonization with an obesity-associated enteropathogenic microbe modulates the premetastatic niches to promote breast cancer lung and liver metastasis

Introduction Obesity, an independent risk factor for breast cancer growth and metastatic progression, is also closely intertwined with gut dysbiosis; and both obese state and dysbiosis promote each other. Enteric abundance of Bacteroides fragilis is strongly linked with obesity, and we recently discovered the presence of B. fragilis in malignant breast cancer. Given that enterotoxigenic B. fragilis or ETBF, which secretes B. fragilis toxin (BFT), has been identified as a procarcinogenic microbe in breast cancer, it is necessary to examine its impact on distant metastasis and underlying systemic and localized alterations promoting metastatic progression of breast cancer. Methods We used syngeneic mammary intraductal (MIND) model harboring gut colonization with ETBF to query distant metastasis of breast cancer cells. Alterations in the immune network and cytokines/chemokines in the tumor microenvironment and distant metastatic sites were examined using flow cytometry, immunohistochemistry, and multiplex arrays. Results ETBF infection initiates a systemic inflammation aiding in the establishment of the premetastatic niche formation in vital organs via increased proinflammatory and protumorigenic cytokines like IL17A, IL17E, IL27p28, IL17A/F, IL6, and IL10 in addition to creating a prometastatic immunosuppressive environment in the liver and lungs rich in myeloid cells, macrophages, and T regulatory cells. It induces remodeling of the tumor microenvironment via immune cell and stroma infiltration, increased vasculogenesis, and an EMT-like response, thereby encouraging early metastatic dissemination ready to colonize the conducive environment in liver and lungs of the breast tumor-bearing mice. Discussion In this study, we show that enteric ETBF infection concomitantly induces systemic inflammation, reshapes the tumor immune microenvironment, and creates conducive metastatic niches to potentiate early dissemination and seeding of metastases to liver and lung tissues in agreement with the “seed and soil hypothesis.” Our results also support the ETBF-induced “parallel model” of metastasis that advocates for an early dissemination of tumor cells that form metastatic lesions independent of the primary tumor load.

[1]  D. Sharma,et al.  The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful! , 2023, Gut microbes.

[2]  S. Siddharth,et al.  Concomitant analyses of intratumoral microbiota and genomic features reveal distinct racial differences in breast cancer , 2023, npj Breast Cancer.

[3]  Ling Yang,et al.  The critical role of gut microbiota in obesity , 2022, Frontiers in Endocrinology.

[4]  Xue-zhen Zhu,et al.  Gut microbiota accelerates obesity in peri-/post-menopausal women via Bacteroides fragilis and acetic acid , 2022, International Journal of Obesity.

[5]  I. Barman,et al.  Label-Free Vibrational and Quantitative Phase Microscopy Reveals Remarkable Pathogen-Induced Morphomolecular Divergence in Tumor-Derived Cells. , 2022, ACS sensors.

[6]  B. Lutz,et al.  The Microbiome and Gut Endocannabinoid System in the Regulation of Stress Responses and Metabolism , 2022, Frontiers in Cellular Neuroscience.

[7]  Yue Zhang,et al.  Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer , 2022, Cell.

[8]  Fan Yang,et al.  Effects of Konjaku Flour on the Gut Microbiota of Obese Patients , 2022, Frontiers in Cellular and Infection Microbiology.

[9]  Chenguang Wang,et al.  Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression , 2021, eLife.

[10]  Liaoliao Dong,et al.  Neutrophils in cancer carcinogenesis and metastasis , 2021, Journal of Hematology & Oncology.

[11]  Tejaswini Appidi,et al.  The role played by bacterial infections in the onset and metastasis of cancer , 2021, Current research in microbial sciences.

[12]  I. Barman,et al.  Vibrational spectroscopy for decoding cancer microbiota interactions: Current evidence and future perspective. , 2021, Seminars in cancer biology.

[13]  J. Raes,et al.  Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice , 2021, Gut.

[14]  Ezanee Azlina Mohamad Hanif,et al.  Pathogens and Carcinogenesis: A Review , 2021, Biology.

[15]  R. Ganju,et al.  Lipopolysaccharide from the commensal microbiota of the breast enhances cancer growth: role of S100A7 and TLR4 , 2021, Molecular oncology.

[16]  C. Eng,et al.  Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer , 2021, Genome medicine.

[17]  Xuelian Song,et al.  The potential role and status of IL-17 family cytokines in breast cancer. , 2021, International immunopharmacology.

[18]  K. Konstantopoulos,et al.  A pro-carcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates Notch and βcatenin axes. , 2021, Cancer discovery.

[19]  K. Varley,et al.  The lingering mysteries of metastatic recurrence in breast cancer , 2020, British journal of cancer.

[20]  D. Sharma,et al.  The Microbiome and Cancer: Creating Friendly Neighborhoods and Removing the Foes Within , 2020, Cancer Research.

[21]  Aaron W. Miller,et al.  The development of metabolic endotoxemia is dependent on the type of sweetener and the presence of saturated fat in the diet , 2020, Gut microbes.

[22]  J. Vogel,et al.  Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression , 2020, Nature Communications.

[23]  Noam Shental,et al.  The human tumor microbiome is composed of tumor type–specific intracellular bacteria , 2020, Science.

[24]  Tamara L. Kinzer-Ursem,et al.  The Dynamic Relationship of Breast Cancer Cells and Fibroblasts in Fibronectin Accumulation at Primary and Metastatic Tumor Sites , 2020, Cancers.

[25]  D. Sharma,et al.  Microbial Alterations and Risk Factors of Breast Cancer: Connections and Mechanistic Insights , 2020, Cells.

[26]  W. Demark-Wahnefried,et al.  Fecal Akkermansia muciniphila Is Associated with Body Composition and Microbiota Diversity in Overweight and Obese Women with Breast Cancer Participating in a Presurgical Weight Loss Trial. , 2020, Journal of the Academy of Nutrition and Dietetics.

[27]  E. Di Carlo Decoding the Role of Interleukin-30 in the Crosstalk between Cancer and Myeloid Cells , 2020, Cells.

[28]  J. Ferlay,et al.  Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. , 2019, The Lancet. Global health.

[29]  D. Sharma,et al.  The Microbiome–Estrogen Connection and Breast Cancer Risk , 2019, Cells.

[30]  Xiaoxia Li,et al.  The role of interleukin-17 in tumor development and progression , 2019, The Journal of experimental medicine.

[31]  K. Gee,et al.  IL-27, IL-30, and IL-35: A Cytokine Triumvirate in Cancer , 2019, Front. Oncol..

[32]  A. Nawaz,et al.  Linkage of CD8+ T cell exhaustion with high-fat diet-induced tumourigenesis , 2019, Scientific Reports.

[33]  D. Sharma,et al.  The power of small changes: Comprehensive analyses of microbial dysbiosis in breast cancer , 2019, Biochimica et biophysica acta. Reviews on cancer.

[34]  M. Sang,et al.  Effect of gastrointestinal microbiome and its diversity on the expression of tumor-infiltrating lymphocytes in breast cancer , 2019, Oncology letters.

[35]  F. Antonicelli,et al.  The Interleukin-17 Family of Cytokines in Breast Cancer , 2018, International journal of molecular sciences.

[36]  William H. Bisson,et al.  Gut microbiota and intestinal FXR mediate the clinical benefits of metformin , 2018, Nature Medicine.

[37]  C. Donati,et al.  Characterization of human breast tissue microbiota from core needle biopsies through the analysis of multi hypervariable 16S-rRNA gene regions , 2018, Scientific Reports.

[38]  J. Suttles,et al.  Circulating Adipose Fatty Acid Binding Protein Is a New Link Underlying Obesity-Associated Breast/Mammary Tumor Development. , 2018, Cell metabolism.

[39]  Junjie Yang,et al.  Study of Microbiomes in Aseptically Collected Samples of Human Breast Tissue Using Needle Biopsy and the Potential Role of in situ Tissue Microbiomes for Promoting Malignancy , 2018, Front. Oncol..

[40]  Qibin Li,et al.  Breast cancer in postmenopausal women is associated with an altered gut metagenome , 2018, Microbiome.

[41]  Mimi Y. Kim,et al.  Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women , 2017, Cancer Epidemiology, Biomarkers & Prevention.

[42]  Huijue Jia,et al.  Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention , 2017, Nature Medicine.

[43]  Eva M. Schmelz,et al.  N-(3-oxododecanoyl)-L-homoserine lactone interactions in the breast tumor microenvironment: Implications for breast cancer viability and proliferation in vitro , 2017, bioRxiv.

[44]  F. Antonicelli,et al.  Interleukin 17 in the tumor microenvironment: A potent target for anticancer immunotherapy? , 2017 .

[45]  D. Ribatti,et al.  Interleukin-30 Promotes Breast Cancer Growth and Progression. , 2016, Cancer research.

[46]  Krishna R. Kalari,et al.  The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Disease , 2016, Scientific Reports.

[47]  G. Gloor,et al.  The Microbiota of Breast Tissue and Its Association with Breast Cancer , 2016, Applied and Environmental Microbiology.

[48]  S. Love,et al.  Characterization of the microbiome of nipple aspirate fluid of breast cancer survivors , 2016, Scientific Reports.

[49]  F. Groppo,et al.  Correlation between body mass index and faecal microbiota from children. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[50]  X. Zhang,et al.  Interleukin-17 Could Promote Breast Cancer Progression at Several Stages of the Disease , 2015, Mediators of inflammation.

[51]  Catherine C. Park,et al.  Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. , 2015, Integrative biology : quantitative biosciences from nano to macro.

[52]  D. Tiezzi,et al.  IL17 Promotes Mammary Tumor Progression by Changing the Behavior of Tumor Cells and Eliciting Tumorigenic Neutrophils Recruitment. , 2015, Cancer research.

[53]  J. Eliaou,et al.  Abstract 3171: IL-25/IL-17E does not induce breast tumor cell apoptosis and both IL-17A and IL-25/IL-17E contribute to breast cancer survival and proliferation associated with generation of pro-oncogenic low molecular forms of cyclin E , 2015 .

[54]  M. Chew,et al.  Overexpression of IL-15 promotes tumor destruction via NK1.1+ cells in a spontaneous breast cancer model , 2015, BMC Cancer.

[55]  J. Ward,et al.  Gut bacteria require neutrophils to promote mammary tumorigenesis , 2015, Oncotarget.

[56]  O. De Wever,et al.  The Quorum Sensing Peptides PhrG, CSP and EDF Promote Angiogenesis and Invasion of Breast Cancer Cells In Vitro , 2015, PloS one.

[57]  B. Hennessy,et al.  Obesity Correlation With Metastases Development and Response to First-Line Metastatic Chemotherapy in Breast Cancer , 2015, Clinical Medicine Insights. Oncology.

[58]  I. Arts,et al.  The intestinal microbiota composition and weight development in children: the KOALA Birth Cohort Study , 2014, International Journal of Obesity.

[59]  H. Gruber,et al.  Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12/SDF-1 expression in the metastatic niches , 2014, BMC Cancer.

[60]  J. Shamonki,et al.  Microbial Dysbiosis Is Associated with Human Breast Cancer , 2014, PloS one.

[61]  J. Eliaou,et al.  IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2 , 2013, Scientific Reports.

[62]  D. Yahav,et al.  Gut bacterial microbiota and obesity. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[63]  Y. Yamaoka,et al.  Helicobacter pylori outer membrane proteins on gastric mucosal interleukin 6 and 11 expression in Mongolian gerbils , 2011, Journal of gastroenterology and hepatology.

[64]  C. Sears,et al.  Enterotoxigenic Bacteroides fragilis (ETBF)-mediated colitis in Min (Apc+/-) mice: a human commensal-based murine model of colon carcinogenesis , 2010, Cell cycle.

[65]  D. Redelman,et al.  The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci , 2007, International journal of experimental pathology.

[66]  Jide Wang,et al.  Helicobacter pylori Infection Induces Oxidative Stress and Programmed Cell Death in Human Gastric Epithelial Cells , 2007, Infection and Immunity.

[67]  A. Tzianabos,et al.  Diversity of the Metalloprotease Toxin Produced by Enterotoxigenic Bacteroides fragilis , 2002, Infection and Immunity.

[68]  E. Mortani,et al.  Intestinal Microflora as an Alternative Metabolic Source of Estrogens in Women with Uterine Leiomyoma and Breast Cancer , 1990 .

[69]  M. Ewertz,et al.  Effect of obesity on prognosis after early-stage breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.